Depressive symptoms as predictors of mortality in patients with COPD

Chest

Volumn 135, Issue 3, 2009, Pages 619-625

  De Voogd, Jacob N ^a   Wempe, Johan B ^a   Koëter, Gerard H ^a   Postema, Klaas ^a   Van Sonderen, Eric ^a   Ranchor, Adelita V ^a   Coyne, James C ^b   Sanderman, Robbert ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

COPD; Depression; Psychology; Pulmonary rehabilitation; Smoking

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL TIME; SYMPTOM;

EID: 62149136593     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-0078     Document Type: Article

References (48)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349:1269-1276
2. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276
3. Hansen EF, Vestbo J, Phanareth K, et al. Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:690- 693
4. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124:459-467
5. Nizet TA, van den Elshout FJ, Heijdra YF, et al. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia. Chest 2005; 127:1904-1910
6. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121:1434-1440
7. Schols M. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1791-1797
8. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1856-1861
9. Pinto-Plata VM, Cote C, Cabral H, et al. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23:28-33
10. Oga T, Nishimura K, Tsukino M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of Wpeak and health status. Am J Respir Crit Care Med 2003; 167:544-549
11. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:680-685
12. Bowen JB, Votto JJ, Thrall RS, et al. Functional status and survival following pulmonary rehabilitation. Chest 2000; 118:697-703
13. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and Wpeak index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005-1012
14. Covinsky E, Kahana E, Chin MH, et al. Depressive symptoms and 3-year mortality in older hospitalized medical patients. Ann Intern Med 1999; 130:563-569
15. Wells KB, Rogers W, Burnam MA, et al. Course of depression in patients with hypertension, myocardial infarction, or insulin-dependent diabetes. Am J Psychiatry 1993; 150:632-638
16. Mykletun A, Bjerkeset O, Dewey M, et al. Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med 2007; 69:323-331
17. Lesperance F, Frasure-Smith N, Talajic M, et al. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105:1049-1053
18. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91:999-1005
19. van Manen JG, Bindels PJ, Dekker FW, et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002; 57:412-416
20. van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 1999; 54:688-692
21. Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005; 127:1205-1211
22. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:14-20
23. Almagro P, Calbo E, Ochoa-de-Echaguen A, et al. Mortality after hospitalization for COPD. Chest 2002; 121:1441-1448
24. Ng TP, Niti M, Tan WC, et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167:60-67
25. Fan VS, Ramsey SD, Giardino ND, et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007; 167:2345-2353
26. Yohannes AM, Baldwin RC, Connolly M. Mortality predictors in disabling chronic obstructive pulmonary disease in old age. Age Ageing 2002; 31:137-140
27. Stage KB, Middelboe T, Pisinger C. Depression and chronic obstructive pulmonary disease (COPD): impact on survival. Acta Psychiatr Scand 2005; 111:320-323
28. American Thoracic Society. Pulmonary rehabilitation: 1999. Am J Respir Crit Care Med 1999; 159:1666-1682
29. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
30. Richter P, Werner J, Heerlein A, et al. On the validity of the Beck Depression Inventory: a review. Psychopathology 1998; 31:160-168
31. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988; 8:77-100
32. Varray A, Prefaut C. Exercise training in patients with respiratory disease: procedures and results. Eur Respir Rev 1995; 5:25-58
33. Gottlieb SS. Dead is dead: artificial definitions are no substitute. Lancet 1997; 349:662-663
34. Irvine J, Basinski A, Baker B, et al. Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med 1999; 61:729-737
35. Mendes de Leon CF. Depression and social support in recovery from myocardial infarction: confounding and confusion. Psychosom Med 1999; 61:738-739
36. Sorensenf C, Friis Hasche E, Haghfelt T, et al. Postmyocardial infarction mortality in relation to depression: a systematic critical review. Psychother Psychosom 2005; 74:69-80
37. de Jonge P, Ormel J, van den Brink RH, et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry 2006; 163:138-144
38. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996
39. Simon GE, Von Korff M, Lin E. Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness. Psychol Med 2005; 35:271-279
40. Barth J, Schumacher M, Herrmann Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66:802-813
41. Thombs BD, Magyar-Russell G, Bass EB, et al. Performance characteristics of depression screening instruments in survivors of acute myocardial infarction: review of the evidence. Psychosomatics 2007; 48:185-194
42. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000; 23:477-501
43. Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol 2001; 57:141-152
44. Rosmond R, Bjorntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med 2000; 247:188-197
45. Macleod J, Davey-Smith G. Psychosocial factors and public health: a suitable case for treatment? J Epidemiol Community Health 2003; 57:565-570
46. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173:1390-1413
47. Everson Rose SA, House JS, Mero RP. Depressive symptoms and mortality risk in a national sample: confounding effects of health status. Psychosom Med 2004; 66:823-830
48. Trentini CM, Xavier FM, Chachamovich E, et al. The influence of somatic symptoms on the performance of elders in the Beck Depression Inventory (BDI). Rev Bras Psiquiatr 2005; 27:119-123